Anna-Giulia Loi

Statistics

Publications

Citations

231

H-Index

Active since

2001

Affiliations

Idera Pharmaceuticals (United States)(Current)

Montpellier GenomiX

Anna-Giulia Loi is an author at Idera Pharmaceuticals (United States) specializing in medicinal chemistry, antiviral structure-activity relationships, and viral hepatitis.

Publications per year

2001–2015

Publications

Antiviral <scp>l</scp> -Nucleosides Specific for Hepatitis B Virus Infection

Martin L. Bryant, Edward G. Bridges, L Placidi et al. · Antimicrobial Agents and Chemotherapy · 2001 · 179 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +16

Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320

Christophe Parsy, François-René Alexandre, Valérie Bidau et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 27 citations

Life Sciences, Infectious Diseases, Medicinal Chemistry +14

Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease

Christophe Parsy, François-René Alexandre, Guillaume Brandt et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease

François-René Alexandre, Guillaume Brandt, Catherine Caillet et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 12 citations

Medicine, Medicinal Chemistry, Pharmacology +16

1–4 of 4